|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ploussard G, Shariat SF, Dragomir A, Kluth
LA, Xylinas E, Masson-Lecomte A, Rieken M, Rink M, Matsumoto K,
Kikuchi E, et al: Conditional survival after radical cystectomy for
bladder cancer: Evidence for a patient changing risk profile over
time. Eur Urol. 66:361–370. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ling H, Fabbri M and Calin GA: MicroRNAs
and other non-coding RNAs as targets for anticancer drug
development. Nat Rev Drug Discov. 12:847–865. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
5
|
Dykes IM and Emanueli C: Transcriptional
and Post-transcriptional Gene Regulation by Long Non-coding RNA.
Genomics Proteomics Bioinformatics. 15:177–186. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Carlson HL, Quinn JJ, Yang YW, Thornburg
CK, Chang HY and Stadler HS: lncRNA-HIT functions as an epigenetic
regulator of chondrogenesis through its recruitment of p100/CBP
Complexes. PLoS Genet. 11(e1005680)2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Cui Y, Zhang F, Zhu C, Geng L, Tian T and
Liu H: Upregulated lncRNA SNHG1 contributes to progression of
non-small cell lung cancer through inhibition of miR-101-3p and
activation of Wnt/β-catenin signaling pathway. Oncotarget.
8:17785–17794. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hu Y, Ma Z, He Y, Liu W, Su Y and Tang Z:
lncRNA-SNHG1 contributes to gastric cancer cell proliferation by
regulating DNMT1. Biochem Biophys Res Commun. 491:926–931.
2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Liu Y, Yang Y, Li L, Liu Y, Geng P, Li G
and Song H: lncRNA SNHG1 enhances cell proliferation, migration,
and invasion in cervical cancer. Biochem Cell Biol. 96:38–43.
2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Chen Y, Wang T, Du J, Li Y, Wang X, Zhou
Y, Yu X, Fan W, Zhu Q, Tong X and Wang Y: The Critical Role of
PTEN/PI3K/AKT signaling pathway in shikonin-induced apoptosis and
proliferation inhibition of chronic myeloid leukemia. Cell Physiol
Biochem. 47:981–993. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Singh S, Asal R and Bhagat S:
Multifunctional antioxidant nanoliposome-mediated delivery of PTEN
plasmids restore the expression of tumor suppressor protein and
induce apoptosis in prostate cancer cells. J Biomed Mater Res A.
106:3152–3164. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhang Y, Zhang R, Luo G and Ai K: Long
noncoding RNA SNHG1 promotes cell proliferation through PI3K/AKT
signaling pathway in pancreatic ductal adenocarcinoma. J Cancer.
9:2713–2722. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ward JF and Margulis V: Continous
improvement of TNM staging system for bladder cancer. Cancer.
115:704–705. 2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Poyet C, Thomas L, Benoit TM, Delmo DA,
Luberto L, Banzola I, Günthart MS, Sais G, Eberli D, Sulser T and
Provenzano M: Implication of vascular endothelial growth factor A
and C in revealing diagnostic lymphangiogenic markers in
node-positive bladder cancer. Oncotarget. 8:21871–2183.
2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Annels NE, Arif M, Simpson GR, Denyer M,
Moller-Levet C, Mansfield D, Butler R, Shafren D, Au G, Knowles M,
et al: Oncolytic immunotherapy for bladder cancer using Coxsackie
A21 virus. Mol Ther Oncolytics. 9:1–12. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Gao Y, Wu K, Chen Y, Zhou J, Du C, Shi Q,
Xu S, Jia J, Tang X, Li F, et al: Beyond proliferation: KLF5
promotes angiogenesis of bladder cancer through directly regulating
VEGFA transcription. Oncotarget. 6:43791–43805. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Pei Z, Du X, Song Y, Fan L, Li F, Gao Y,
Wu R, Chen Y, Li W, Zhou H, et al: Down-regulation of lncRNA CASC2
promotes cell proliferation and metastasis of bladder cancer by
activation of the Wnt/β-catenin signaling pathway. Oncotarget.
8:18145–18153. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wang Y, Shi F, Xia Y and Zhao H: lncRNA
OIP5-AS1 predicts poor prognosis and regulates cell proliferation
and apoptosis in bladder cancer. J Cell Biochem: Nov 28, 2018 (Epub
ahead of print). doi: 10.1002/jcb.28024.
|
|
20
|
Gao R, Zhang N, Yang J, Zhu Y, Zhang Z,
Wang J, Xu X, Li Z, Liu X, Li Z, et al: Long non-coding RNA
ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration
and invasion induced by TGF-β1 in bladder cancer cells. J Exp Clin
Cancer Res. 38(111)2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Lu Q, Shan S, Li Y, Zhu D, Jin W and Ren
T: Long noncoding RNA SNHG1 promotes non-small cell lung cancer
progression by up-regulating MTDH via sponging miR-145-5p. FASEB J.
32:3957–3967. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Cui L, Dong Y, Wang X, Zhao X, Kong C, Liu
Y, Jiang X and Zhang X: Downregulation of long noncoding RNA SNHG1
inhibits cell proliferation, metastasis, and invasion by
suppressing the Notch-1 signaling pathway in pancreatic cancer. J
Cell Biochem. 120:6106–6112. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li Z, Li X, Du X, Zhang H, Wu Z, Ren K and
Han X: The Interaction Between lncRNA SNHG1 and miR-140 in
regulating growth and tumorigenesis via the TLR4/NF-κB pathway in
cholangiocarcinoma. Oncol Res. 27:663–672. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Deng R, Zhang J and Chen J: lncRNA SNHG1
negatively regulates miRNA1013p to enhance the expression of ROCK1
and promote cell proliferation, migration and invasion in
osteosarcoma. Int J Mol Med. 43:1157–1166. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Pistritto G, Trisciuoglio D, Ceci C,
Garufi A and D'Orazi G: Apoptosis as anticancer mechanism: Function
and dysfunction of its modulators and targeted therapeutic
strategies. Aging (Albany NY). 8:603–619. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Gan H, Zhang Y, Zhou Q, Zheng L, Xie X,
Veeraraghavan VP and Mohan SK: Zingerone induced caspase-dependent
apoptosis in MCF-7 cells and prevents
7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in
experimental rats. J Biochem Mol Toxicol. 33(e22387)2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Warren CFA, Wong-Brown MW and Bowden NA:
BCL-2 family isoforms in apoptosis and cancer. Cell Death Dis.
10(177)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Mirakhor Samani S, Ezazi Bojnordi T,
Zarghampour M, Merat S and Fouladi DF: Expression of p53, Bcl-2 and
Bax in endometrial carcinoma, endometrial hyperplasia and normal
endometrium: A histopathological study. J Obstet Gynaecol.
38:999–1004. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Tjalma WA, Weyler JJ, Bogers JJ,
Pollefliet C, Baay M, Goovaerts GC, Vermorken JB, van Dam PA, van
Marck EA and Buytaert PM: The importance of biological factors
(bcl-2, bax, p53, PCNA, MI, HPV and angiogenesis) in invasive
cervical cancer. Eur J Obstet Gynecol Reprod Biol. 97:223–230.
2001.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Paluch EK, Aspalter IM and Sixt M: Focal
adhesion-independent cell migration. Annu Rev Cell Dev Biol.
32:469–490. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Cao ZQ, Wang Z and Leng P: Aberrant
N-cadherin expression in cancer. Biomed Pharmacother.
118(109320)2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Siret C, Terciolo C, Dobric A, Habib MC,
Germain S, Bonnier R, Lombardo D, Rigot V and André F: Interplay
between cadherins and α2β1 integrin differentially regulates
melanoma cell invasion. Br J Cancer. 113:1445–1453. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Derycke LD and Bracke ME: N-cadherin in
the spotlight of cell-cell adhesion, differentiation,
embryogenesis, invasion and signalling. Int J Dev Biol. 48:463–476.
2004.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wang Y, Kuang H, Xue J, Liao L, Yin F and
Zhou X: lncRNA AB073614 regulates proliferation and metastasis of
colorectal cancer cells via the PI3K/AKT signaling pathway. Biomed
Pharmacother. 93:1230–1237. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zhang J, Li J, Li S, Zhou C, Qin Y and Li
X: miR802 inhibits the aggressive behaviors of nonsmall cell lung
cancer cells by directly targeting FGFR1. Int J Oncol.
54:2211–2222. 12019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhang H, Pan YZ, Cheung M, Cao M, Yu C,
Chen L, Zhan L, He ZW and Sun CY: LAMB3 mediates apoptotic,
proliferative, invasive, and metastatic behaviors in pancreatic
cancer by regulating the PI3K/Akt signaling pathway. Cell Death
Dis. 10(230)2019.PubMed/NCBI View Article : Google Scholar
|
